BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8093401)

  • 1. Retinoid resistance.
    Warrell RP
    Lancet; 1993 Jan; 341(8837):126. PubMed ID: 8093401
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of all-trans retinoid acid pharmacokinetics in acute promyelocytic leukaemia by prolonged interferon-alpha therapy.
    Lazzarino M; Corso A; Regazzi MB; Iacona I; Bernasconi C
    Br J Haematol; 1995 Aug; 90(4):928-30. PubMed ID: 7669674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-trans retinoic acid in myelogenous leukaemia.
    Gallagher RE; Wiernik PH
    Lancet; 1991 Dec 21-28; 338(8782-8783):1603. PubMed ID: 1684016
    [No Abstract]   [Full Text] [Related]  

  • 4. Itraconazole and retinoid resistance.
    Ueno H; Kizaki M; Takayama N; Matsushita H; Muto A; Okamoto S; Ikeda Y
    Am J Hematol; 1995 Dec; 50(4):319-20. PubMed ID: 7485119
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon alfa-2a tretinoin in patients with metastatic renal cell carcinoma: a pilot study.
    Paule B; Bonhomme-Faivre L; Rudant E; Ferrière F
    Am J Health Syst Pharm; 1997 Jan; 54(2):190-2. PubMed ID: 9117809
    [No Abstract]   [Full Text] [Related]  

  • 6. Retinoid resistance in acute promyelocytic leukemia: new mechanisms, strategies, and implications.
    Warrell RP
    Blood; 1993 Oct; 82(7):1949-53. PubMed ID: 8400247
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current therapy of acute promyelocytic leukemia using vitamin A derivatives].
    Löwenberg B; Budel LM
    Ned Tijdschr Geneeskd; 1993 Apr; 137(16):796-8. PubMed ID: 8487880
    [No Abstract]   [Full Text] [Related]  

  • 8. [Arsenic treatment for leukemia: new model of human cancer target treatment].
    Zhao WW; Chen SJ
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):439-40. PubMed ID: 15854545
    [No Abstract]   [Full Text] [Related]  

  • 9. Retinoid differentiation therapy in promyelocytic leukemia.
    Chomienne C; Fenaux P; Degos L
    FASEB J; 1996 Jul; 10(9):1025-30. PubMed ID: 8801163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retinoid therapy of acute promyelocytic leukemia].
    Ellegaard J
    Ugeskr Laeger; 1994 Mar; 156(11):1660. PubMed ID: 8009665
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful remission induction by low-dose all-trans retinoic acid alone in a patient with acute promyelocytic leukemia and renal impairment.
    Matsumoto K; Tamaki H; Yamagami T; Sasaki N; Hara S; Soma T
    Leuk Res; 2008 Mar; 32(3):512-4. PubMed ID: 17588659
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current progress in the treatment of acute promyelocytic leukemia with retinoic acid].
    Zeng H; Zhao XY
    Zhonghua Nei Ke Za Zhi; 1994 Dec; 33(12):848-50. PubMed ID: 7768144
    [No Abstract]   [Full Text] [Related]  

  • 13. Retinoids and cancer therapy.
    Claxton DF; Plunkett W; Andreeff M; Deisseroth AB
    J Natl Cancer Inst; 1992 Sep; 84(17):1306-7. PubMed ID: 1495098
    [No Abstract]   [Full Text] [Related]  

  • 14. Filgrastim combined with tretinoin in acute promyelocytic leukaemia.
    Usuki K; Ikeda Y; Kitazume K; Iwabe K; Okuyama Y; Urabe A
    Lancet; 1994 Mar; 343(8900):803-4. PubMed ID: 7510817
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical relevance of all-trans retinoic acid pharmacokinetics and its modulation in acute promyelocytic leukemia.
    Lazzarino M; Regazzi MB; Corso A
    Leuk Lymphoma; 1996 Nov; 23(5-6):539-43. PubMed ID: 9031084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced plasma all-trans retinoic acid level in a patient with Crohn's disease with acute promyelocytic leukemia.
    Takitani K; Inoue A; Kawakami C; Miyazaki H; Aomatsu T; Yoden A; Suzuki K; Tamai H
    Leuk Lymphoma; 2009 Feb; 50(2):300-2. PubMed ID: 19160127
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of all-trans retinoic acid in adults and children with acute promyelocytic leukemia.
    Takitani K; Koh M; Inoue A; Kawakami C; Kuno T; Tamai H
    Am J Hematol; 2006 Sep; 81(9):720-1. PubMed ID: 16838336
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of acute leukemia by differentiation: effects of all trans retinoic acid in acute promyelocytic leukemia].
    Degos L
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):193-5. PubMed ID: 8337123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-trans-retinoic acid: what is it good for?
    Warrell RP
    J Clin Oncol; 1992 Nov; 10(11):1659-61. PubMed ID: 1403047
    [No Abstract]   [Full Text] [Related]  

  • 20. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
    Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
    N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.